Heartflow Research Development from 2010 to 2026

HTFL Stock   27.74  1.75  6.73%   
Heartflow Common Research Development yearly trend continues to be quite stable with very little volatility. The value of Research Development is projected to decrease to about 43.7 M. From the period between 2010 and 2026, Heartflow Common, Research Development regression line of its data series had standard deviation of  4,101,893 and standard deviation of  4,101,893. View All Fundamentals
 
Research Development  
First Reported
2010-12-31
Previous Quarter
50 M
Current Value
43.7 M
Quarterly Volatility
4.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Heartflow Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heartflow Common's main balance sheet or income statement drivers, such as Tax Provision of 45.3 K, Interest Income of 3.8 M or Depreciation And Amortization of 8.6 M, as well as many indicators such as Price To Sales Ratio of 19.51, Dividend Yield of 0.0 or Days Sales Outstanding of 95.04. Heartflow financial statements analysis is a perfect complement when working with Heartflow Common Valuation or Volatility modules.
Check out the analysis of Heartflow Common Correlation against competitors.
Historical Research Development data for Heartflow Common serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Heartflow Common Stock represents a compelling investment opportunity.

Latest Heartflow Common's Research Development Growth Pattern

Below is the plot of the Research Development of Heartflow Common Stock over the last few years. It is Heartflow Common's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heartflow Common's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Heartflow Research Development Regression Statistics

Arithmetic Mean37,598,329
Geometric Mean37,413,931
Coefficient Of Variation10.91
Mean Deviation2,873,013
Median35,854,000
Standard Deviation4,101,893
Sample Variance16.8T
Range14.2M
R-Value0.63
Mean Square Error10.9T
R-Squared0.39
Significance0.01
Slope509,099
Total Sum of Squares269.2T

Heartflow Research Development History

202643.7 M
202550 M
202443.5 M

About Heartflow Common Financial Statements

Heartflow Common investors utilize fundamental indicators, such as Research Development, to predict how Heartflow Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development50 M43.7 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Heartflow Common Stock is a strong investment it is important to analyze Heartflow Common's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Heartflow Common's future performance. For an informed investment choice regarding Heartflow Stock, refer to the following important reports:
Check out the analysis of Heartflow Common Correlation against competitors.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heartflow Common. Market participants price Heartflow higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Heartflow Common assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(1.16)
Revenue Per Share
24.786
Quarterly Revenue Growth
0.398
Investors evaluate Heartflow Common Stock using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Heartflow Common's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Heartflow Common's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Heartflow Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heartflow Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Heartflow Common's market price signifies the transaction level at which participants voluntarily complete trades.